| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 12/10/2013 | US8603496 Compositions and methods for biological remodeling with frozen particle compositions |
| 12/10/2013 | US8603495 Compositions and methods for biological remodeling with frozen particle compositions |
| 12/10/2013 | US8603494 Compositions and methods for administering compartmentalized frozen particles |
| 12/10/2013 | US8603493 Carbosilane dendrimers, preparation method thereof and use of same |
| 12/10/2013 | US8603489 Therapeutic proteins from latex |
| 12/10/2013 | US8603464 Alkaline phosphatase to reduce weight gain or induce weight loss |
| 12/10/2013 | US8603455 Removal promoters and inhibitor for apoptosis cells in vivo |
| 12/10/2013 | US8603441 Functionalized calcium phosphate hybrid systems for confectionery and foodstuff applications |
| 12/10/2013 | US8603440 Compressed chewing gum tablet |
| 12/10/2013 | US8603439 Formulations of aminoglycoside and fosfomycin combinations and methods and systems for treatment of ventilator associated pneumonia (VAP) and ventilator associated tracheal (VAT) bronchitis |
| 12/10/2013 | US8603158 Irradiated stent coating |
| 12/10/2013 | US8603076 Microfabricated nanopore device for sustained release of therapeutic agent |
| 12/10/2013 | US8603075 Fluid delivery system with electrochemical sensing of analyte concentration levels |
| 12/10/2013 | US8603051 Implantable drug delivery devices |
| 12/10/2013 | CA2754839C Pharmaceutical composition comprising levamlodipine and chlorthalidone |
| 12/10/2013 | CA2739611C Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient |
| 12/10/2013 | CA2623749C Reduction of saltiness with sweeteners |
| 12/10/2013 | CA2613732C Thermoreversible immuno-adjuvant emulsion |
| 12/10/2013 | CA2565915C Inhalation powder formulations containing enantiomerically pure beta-agonists |
| 12/10/2013 | CA2557848C Ion binding compositions |
| 12/10/2013 | CA2541243C Pressure-sensitive adhesive sheet for application to skin |
| 12/10/2013 | CA2538104C Use of xenon with hypothermia for treating neonatal asphyxia |
| 12/10/2013 | CA2499220C Local vascular delivery of etoposide in combination with rapamycin to prevent restenosis following vascular injury |
| 12/10/2013 | CA2489250C Composition comprising viscous fibers and viscosity-lowering proteins |
| 12/10/2013 | CA2489084C A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product |
| 12/10/2013 | CA2478612C Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist |
| 12/10/2013 | CA2476984C Lactoferrin as an agent for enhancing action of an opioid |
| 12/10/2013 | CA2415325C Preventing airway mucus production by administration of egf-r antagonists |
| 12/05/2013 | WO2013181639A1 Treatment of solid tumors using coenzyme q10 |
| 12/05/2013 | WO2013181566A1 Polysaccharide-based hydrogels and hybrid hydrogels and precursors thereof, methods of making same, and uses thereof |
| 12/05/2013 | WO2013181511A1 Sustained delivery of molecules using peptide surfactants and uses thereof |
| 12/05/2013 | WO2013181449A1 Formulations and methods for vaginal delivery of antiprogestins |
| 12/05/2013 | WO2013181424A1 Cryopreserved implantable cell culture devices and uses thereof |
| 12/05/2013 | WO2013181292A1 Nitisinone formulations |
| 12/05/2013 | WO2013181224A1 Combined therapy and prophylaxis for genital tract infections |
| 12/05/2013 | WO2013181107A1 Bioactive agent delivery devices and methods of making and using the same |
| 12/05/2013 | WO2013180796A1 Methods for treating insomnia |
| 12/05/2013 | WO2013180676A1 A new sustained release formulation |
| 12/05/2013 | WO2013180675A1 Tablet formulation comprising dapoxetine |
| 12/05/2013 | WO2013180606A1 Composition for treatment of warts |
| 12/05/2013 | WO2013180459A2 Catechol graft copolymer, copolymer composition containing crosslinked copolymer, functional adhesive matrix composition, and method for preparing same |
| 12/05/2013 | WO2013180458A1 Crosslinked hydrogel for drug delivery, and method for preparing the hydrogel |
| 12/05/2013 | WO2013180457A1 Antimicrobial organic copolymer having adhesion properties, method for producing same, antimicrobial coating film coated with same, and method for coating the coating film |
| 12/05/2013 | WO2013180253A1 pH-SENSITIVE CARRIER AND METHOD FOR PRODUCTION THEREOF, pH-SENSITIVE MEDICINE AND pH-SENSITIVE PHARMACEUTICAL COMPOSITION EACH CONTAINING SAID CARRIER, AND CULTURE METHOD USING SAID pH-SENSITIVE MEDICINE OR SAID pH-SENSITIVE PHARMACEUTICAL COMPOSITION |
| 12/05/2013 | WO2013180249A1 Cellulose powder |
| 12/05/2013 | WO2013180248A1 Cellulose powder |
| 12/05/2013 | WO2013180246A1 Cellulose powder |
| 12/05/2013 | WO2013180140A1 Dihydroorotic acid dehydrogenase inhibitor |
| 12/05/2013 | WO2013180008A1 Sebum-absorbent pasting material, and method for manufacturing same |
| 12/05/2013 | WO2013179669A1 Carrier for gene introduction use, gene introduction agent, methods for producing said carrier and said gene introduction agent, and method for introducing gene into cell |
| 12/05/2013 | WO2013179307A2 Stabilized pharmaceutical compositions of saxagliptin |
| 12/05/2013 | WO2013179302A1 Oral anti-inflammatory formulation comprising potentised cytokine |
| 12/05/2013 | WO2013179258A1 New release system of hydrophobic proteins |
| 12/05/2013 | WO2013179248A1 Pharmaceutical compositions of pemetrexed |
| 12/05/2013 | WO2013179206A1 Mineral supplementation of beverages |
| 12/05/2013 | WO2013178954A1 Improved organic-inorganic hybrid solid having a modified outer surface |
| 12/05/2013 | WO2013178880A1 Composition for preventing headaches |
| 12/05/2013 | WO2013178817A1 Palatable oral veterinary compositions |
| 12/05/2013 | WO2013178811A1 Paliperidone implant formulation |
| 12/05/2013 | WO2013178802A2 Microparticles and a system and method for the synthesis of microparticles |
| 12/05/2013 | WO2013178788A2 Manufacture of degarelix |
| 12/05/2013 | WO2013178771A1 Syringe |
| 12/05/2013 | WO2013178758A1 O/w-emulsion-type topical pharmaceutical compositions containing a retinoid |
| 12/05/2013 | WO2013178756A1 Dermatological composition including oleosomes and retinoids, method for preparing same and use thereof |
| 12/05/2013 | WO2013178752A1 Method for preparing a dermatological composition including oleosomes |
| 12/05/2013 | WO2013178749A1 Lipid nanocapsules comprising a retinoid, nanodispersion and composition containing same, method of producing same and use thereof in dermatology |
| 12/05/2013 | WO2013178744A1 Emulsion-type, emulsifier-free topical compositions containing stabilising particles |
| 12/05/2013 | WO2013178743A1 Microcapsules containing retinoids, method for preparing same, and pharmaceutical compositions containing same |
| 12/05/2013 | WO2013178742A1 Novel dosage form and formulation of abediterol |
| 12/05/2013 | WO2013178713A1 Stabilized granules containing glyceryl trinitrate for inducing arteriogenesis |
| 12/05/2013 | WO2013178631A1 Nanoparticles for targeting for a biological application |
| 12/05/2013 | WO2013178587A1 Use of n-acetyl-5-methoxytryptamine or analogues thereof, for promoting the mechanism of implantation of the embryo and related compositions and culture media |
| 12/05/2013 | WO2013178214A1 Pharmaceutical pemetrexed solution |
| 12/05/2013 | WO2013177963A1 Injection-use pantoprazole sodium lyophilized powder composition and preparation method therefor |
| 12/05/2013 | WO2013177948A1 Application of composition in preparing health care product or medicine for preventing and treating leukopenia caused by radiotherapy and chemotherapy |
| 12/05/2013 | WO2013177945A1 Composition for preventing and treating aids and preparation method thereof |
| 12/05/2013 | WO2013177944A1 Use of composition in preparing health care products or medicines for preventing and treating allergic diseases |
| 12/05/2013 | WO2013177927A1 Injection-use esomeprazole sodium lyophilized powder composition and preparation method therefor |
| 12/05/2013 | WO2013177907A1 Injection-use levorotatory-pantoprazole sodium lyophilized powder composition and preparation method therefor |
| 12/05/2013 | WO2013177833A1 Dysmenorrhea-treating medicament and preparation method therefor |
| 12/05/2013 | WO2013177832A1 Method for detecting medicament for treatment of dysmenorrhea |
| 12/05/2013 | WO2013177672A1 Pharmaceutical composition of entecavir and process of manufacturing |
| 12/05/2013 | WO2013155374A3 Cholesterol efflux assay probe formulations, methods of making and using |
| 12/05/2013 | WO2013150331A4 Acid resistant banding solution for acid resistant two piece hard capsules |
| 12/05/2013 | WO2013147649A3 Inhibitors of the pi3k/akt/ikk/nf-kb signalling pathway, pharmaceutically acceptable salts thereof and compositions containing said inhibitors for the prophylaxis and treatment of viral diseases |
| 12/05/2013 | WO2013144976A3 Chewable soft gelatin capsule dosage form of mucolytic agents |
| 12/05/2013 | WO2013140367A3 Composition for the treatment of pediculosis and corresponding manufacturing process |
| 12/05/2013 | WO2013136192A3 Use of tetracycline compositions for wound treatment and skin restoration |
| 12/05/2013 | WO2013123114A3 Anti-vla1 (cd49a) antibody pharmaceutical compositions |
| 12/05/2013 | WO2013115737A3 New pharmaceutical compositions of flurbiprofen and glucosamin |
| 12/05/2013 | WO2013109354A3 Etravirine formulations and uses thereof |
| 12/05/2013 | WO2013100882A3 Combinations of diacerein and non-steroidal inflammation drugs |
| 12/05/2013 | WO2013095318A3 Orally-disintegrating formulations of flurbiprofen |
| 12/05/2013 | WO2013092860A3 Hyaluronic acid and its use for treating venous insufficiency and varicose veins |
| 12/05/2013 | WO2012120043A3 Method for forming drops of a first phase dispersed in a second phase substantially immiscible with the first phase |
| 12/05/2013 | US20130324950 Transdermal delivery system containing galantamine or salts thereof |
| 12/05/2013 | US20130324941 External Infusion Device with Remote Programming, Bolus Estimator and/or Vibration Alarm Capabilities |
| 12/05/2013 | US20130324940 External Infusion Device with Remote Programming, Bolus Estimator and/or Vibration Alarm Capabilities |
| 12/05/2013 | US20130324612 Aqueous gel formulation and method for inducing topical anesthesia |
| 12/05/2013 | US20130324575 Compositions and method for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate |